Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers
N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24+0 and 36+6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5−88.2) compared to 72.8% (95% CI 67.4−78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926−0.956) vs. 0.901 (95% CI 0.880−0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937−0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890−0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Journal of clinical medicine - 12(2023), 2 vom: 05. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garrido-Giménez, Carmen [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Revised 08.03.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm12020431 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351860851 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351860851 | ||
003 | DE-627 | ||
005 | 20231226052413.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm12020431 |2 doi | |
028 | 5 | 2 | |a pubmed24n1172.xml |
035 | |a (DE-627)NLM351860851 | ||
035 | |a (NLM)36675361 | ||
035 | |a (PII)431 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Garrido-Giménez, Carmen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Predictive Model for Preeclampsia Combining sFlt-1, PlGF, NT-proBNP, and Uric Acid as Biomarkers |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 08.03.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a N-terminal pro-brain natriuretic peptide (NT-proBNP) and uric acid are elevated in pregnancies with preeclampsia (PE). Short-term prediction of PE using angiogenic factors has many false-positive results. Our objective was to validate a machine-learning model (MLM) to predict PE in patients with clinical suspicion, and evaluate if the model performed better than the sFlt-1/PlGF ratio alone. A multicentric cohort study of pregnancies with suspected PE between 24+0 and 36+6 weeks was used. The MLM included six predictors: gestational age, chronic hypertension, sFlt-1, PlGF, NT-proBNP, and uric acid. A total of 936 serum samples from 597 women were included. The PPV of the MLM for PE following 6 weeks was 83.1% (95% CI 78.5−88.2) compared to 72.8% (95% CI 67.4−78.4) for the sFlt-1/PlGF ratio. The specificity of the model was better; 94.9% vs. 91%, respectively. The AUC was significantly improved compared to the ratio alone [0.941 (95% CI 0.926−0.956) vs. 0.901 (95% CI 0.880−0.921), p < 0.05]. For prediction of preterm PE within 1 week, the AUC of the MLM was 0.954 (95% CI 0.937−0.968); significantly greater than the ratio alone [0.914 (95% CI 0.890−0.934), p < 0.01]. To conclude, an MLM combining the sFlt-1/PlGF ratio, NT-proBNP, and uric acid performs better to predict preterm PE compared to the sFlt-1/PlGF ratio alone, potentially increasing clinical precision | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a N-terminal pro-brain natriuretic peptide (NT-proBNP) | |
650 | 4 | |a angiogenic factors | |
650 | 4 | |a machine-learning | |
650 | 4 | |a placental growth factor (PlGF) | |
650 | 4 | |a prediction | |
650 | 4 | |a preeclampsia | |
650 | 4 | |a soluble fms-like tyrosine kinase 1 (sFlt-1) | |
650 | 4 | |a uric acid | |
700 | 1 | |a Cruz-Lemini, Mónica |e verfasserin |4 aut | |
700 | 1 | |a Álvarez, Francisco V |e verfasserin |4 aut | |
700 | 1 | |a Nan, Madalina Nicoleta |e verfasserin |4 aut | |
700 | 1 | |a Carretero, Francisco |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Oliva, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Mora, Josefina |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-García, Olga |e verfasserin |4 aut | |
700 | 1 | |a García-Osuna, Álvaro |e verfasserin |4 aut | |
700 | 1 | |a Alijotas-Reig, Jaume |e verfasserin |4 aut | |
700 | 1 | |a Llurba, Elisa |e verfasserin |4 aut | |
700 | 1 | |a On Behalf Of The EuroPE Working Group |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 12(2023), 2 vom: 05. Jan. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:2 |g day:05 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm12020431 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 2 |b 05 |c 01 |